Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Blankenstein, Thomas Prof. Dr. (1) Janz, Martin Dr. (4) Kieback, Elisa Dr. (1) Kobelt, Dennis Dr. (1) Leisegang, Matthias Dr. (1) Lusatis, Simone (1) Selbach, Matthias Prof. Dr. (2) Wollert-Wulf, Brigitte (2) (-) Mathas, Stephan Dr. (4) (-) Uckert, Wolfgang Prof. Dr. (2) (-) Biologie maligner Lymphome (4) Experimentelle Genetik von Herz- Kreislauferkrankungen (1) Molekulare Immunologie und Gentherapie (1) (-) Molekulare Zellbiologie und Gentherapie (3) 2002 (4) (-) 2006 (6) 2007 (8) 2008 (7) 2010 (12) 2011 (7) 2012 (5) 2014 (10) 2015 (12) 2016 (12) 2017 (7) 2018 (4) 2019 (2) 2020 (4) 2021 (1) 6 Ergebnisse: Active Filter: Mathas, Stephan Dr.Uckert, Wolfgang Prof. Dr.Biologie maligner LymphomeMolekulare Zellbiologie und Gentherapie2006 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Juli 2006 in Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken 15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. März 2006 in Cell Mol Life Sci The translocation motif of hepatitis B virus improves protein vaccination E. Bleifuss T. Kammertoens A. Hutloff D. Quarcoo M. Dorner P. Straub W. Uckert E. Hildt 01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. November 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Juli 2006 in Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
15. Mai 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
15. März 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. März 2006 in Cell Mol Life Sci The translocation motif of hepatitis B virus improves protein vaccination E. Bleifuss T. Kammertoens A. Hutloff D. Quarcoo M. Dorner P. Straub W. Uckert E. Hildt
01. Februar 2006 in Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
